멀티오믹스 시장 : 제품·서비스별, 유형별, 플랫폼별, 용도별, 최종 용도별 - 세계 예측(2023-2032년)

Global Multi-omics Market share will witness 15.2% CAGR between 2023 and 2032, propelled by substantial government investments worldwide. Funding initiatives from governmental bodies catalyze research in genomics, proteomics, and metabolomics, driving innovation in healthcare, agriculture, and environmental sciences.

For instance, in September 2023, the establishment of the Multi-Omics for Health and Disease Consortium by the National Institutes of Health marked a significant step in the market, with an initial funding of about $11 million. This consortium aims to propel the study and analysis of multi-omic data for human health exploration. Multi-omics involves amalgamating various 'omics' data types like genomics, epigenomics, transcriptomics, proteomics, and metabolomics. Each type offers unique insights into biological systems, and harnessing these collectively, enabled by technological advancements and data science, holds immense promise for comprehensive health research.

These investments foster advanced technologies that decode biological complexities, revolutionizing disease diagnosis, personalized medicine, and crop improvement. As governments recognize the transformative potential of multi-omics, increased funding solidifies its market demand, fostering collaborations and pioneering solutions that reshape our understanding and application of biological data across diverse sectors.

The overall Multi-omics Market share is classified based on product & services, application, and region.

Instruments segment will undergo significant development from 2023 to 2032. These tools, adept at analyzing genomics, transcriptomics, proteomics, and metabolomics, fuel innovation in biotechnology and healthcare. High-throughput technologies and sophisticated instruments enable comprehensive data collection, driving insights into complex biological systems. As research endeavors increasingly seek holistic perspectives, the market witnesses amplified demand for cutting-edge instruments capable of unraveling intricate multi-omic data. This demand surge propels the development of more refined and precise analytical tools, shaping the future landscape of multi-omics research and applications.

Multi-omics market size from the cell biology segment will register a noteworthy CAGR from 2023 to 2032. Integrating genomics, transcriptomics, proteomics, and metabolomics, this approach uncovers intricate cellular mechanisms. Advancements in understanding cellular behavior and functions necessitate comprehensive data analysis, driving the surge for multi-omics techniques. This synergy allows researchers to dissect cellular complexities, unveiling new therapeutic targets and insights into diseases. As cell biology delves deeper into intricate molecular interactions, the market witnesses a growing appetite for multi-omics methodologies, shaping transformative strides in biomedical research and healthcare innovations.

Europe multi-omics industry will showcase a commendable CAGR from 2023 to 2032. Leading institutions and funding initiatives drive innovation in genomics, proteomics, metabolomics, and beyond. This collective pursuit of comprehensive data analysis reflects Europe's commitment to advancing healthcare, agriculture, and environmental sciences. With an emphasis on precision medicine and sustainable practices, the continent's growing reliance on multi-omics technologies propels market demand. This fervor for integrated omics approaches underscores Europe's pivotal role in shaping the future of biomedical research and transformative applications across industries.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Multi-omics industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Products & services trends
  • 2.1.4 Type trends
  • 2.1.5 Platform trends
  • 2.1.6 Application trends
  • 2.1.7 End-use trends

Chapter 3 Multi-omics Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Advancements in omics technologies
    • 3.2.1.2 Increasing applications in personalized medicine
    • 3.2.1.3 Rising government initiatives and funding
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of instruments and data storage
    • 3.2.2.2 Complex regulatory requirements and standardization issues
• 3.3 Growth potential analysis
  • 3.3.1 By products & services
  • 3.3.2 By type
  • 3.3.3 By platform
  • 3.3.4 By application
  • 3.3.5 By end-use
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Multi-omics Market Estimates and Forecast, By Products & Services, 2018-2032 (USD Million)

• 5.1 Key trends, by products & services
• 5.2 Products
  • 5.2.1 Instruments
  • 5.2.2 Consumables
  • 5.2.3 Software
• 5.3 Services

Chapter 6 Multi-omics Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

• 6.1 Key trends, by type
• 6.2 Single-cell multi-omics
• 6.3 Bulk multi-omics

Chapter 7 Multi-omics Market Estimates and Forecast, By Platform, 2018-2032 (USD Million)

• 7.1 Key trends, by platform
• 7.2 Genomics
• 7.3 Proteomics
• 7.4 Metabolomics
• 7.5 Transcriptomics
• 7.6 Integrated omics platforms

Chapter 8 Multi-omics Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

• 8.1 Key trends, by application
• 8.2 Cell biology
• 8.3 Oncology
• 8.4 Neurology
• 8.5 Immunology
• 8.6 Other applications

Chapter 9 Multi-omics Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)

• 9.1 Key trends, by end-use
• 9.2 Academic and research organizations
• 9.3 Pharmaceutical & biotechnology companies
• 9.4 Hospital and diagnostic laboratories
• 9.5 Other end-users

Chapter 10 Multi-omics Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 Becton, Dickinson and Company
• 11.2 Thermo Fisher Scientific Inc.
• 11.3 Illumina, Inc
• 11.4 Danaher
• 11.5 PerkinElmer Inc.
• 11.6 Shimadzu Corporation
• 11.7 Bruker
• 11.8 QIAGEN
• 11.9 Agilent Technologies, Inc.
• 11.10 BGI
• 11.11 10x Genomics
• 11.12 CYTENA GmbH